Drug Shortage Report for SAXENDA
| Report ID | 253826 |
| Drug Identification Number | 02437899 |
| Brand name | SAXENDA |
| Common or Proper name | Liraglutide injection |
| Company Name | NOVO NORDISK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LIRAGLUTIDE |
| Strength(s) | 6MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | EA |
| ATC code | A10BJ |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2025-10-01 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2025-07-08 |
| Shortage status | Avoided shortage |
| Updated date | 2025-07-08 |
| Company comments | Product available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
| Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2025-07-08 | French | Compare |
| v6 | 2025-07-08 | English | Compare |
| v5 | 2025-04-01 | French | Compare |
| v4 | 2025-04-01 | English | Compare |
| v3 | 2025-04-01 | French | Compare |
| v2 | 2025-04-01 | French | Compare |
| v1 | 2025-04-01 | English | Compare |
Showing 1 to 7 of 7